Hans Vrielink
Overview
Explore the profile of Hans Vrielink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
387
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwartz J, Vrielink H
Transfus Apher Sci
. 2024 Dec;
64(1):104047.
PMID: 39706128
No abstract available.
2.
Jacobs J, Bates I, Cohn C, Choudhury N, Owusu-Ofori S, Vrielink H, et al.
Lancet
. 2024 Sep;
404(10456):988-990.
PMID: 39244275
The optimum number of units of blood and the associated number of blood donors required to meet a given population's needs remain undetermined globally. Typically, a whole blood donation rate...
3.
Langi Sasongko P, Vrielink H, de Bruijne M
Health Sci Rep
. 2024 Jul;
7(7):e2171.
PMID: 39011149
Background And Aims: The COVID-19 pandemic has revealed the importance of organizational resilience, the ability to effectively respond to a disruptive event before, during, and after it occurs. Team improvisation...
4.
Vrielink H, Le Poole K, Stegmayr B, Kielstein J, Berlin G, Ilhan O, et al.
Transfus Apher Sci
. 2023 Oct;
62(6):103831.
PMID: 37827962
The WAA apheresis registry contains data on more than 140,000 apheresis procedures conducted in 12 different countries. The aim is to give an update of indications, type and number of...
5.
Shermadini K, Alkhazashvili M, Vrielink H, Smid W, Getia V, Gamkrelidze A, et al.
Transfus Apher Sci
. 2023 Sep;
62(5):103807.
PMID: 37673755
No abstract available.
6.
Vrielink H, Smid W
Transfus Apher Sci
. 2023 Sep;
62(5):103796.
PMID: 37657947
No abstract available.
7.
Worel N, Holbro A, Vrielink H, Ootjers C, Le Poole K, Beer-Wekking I, et al.
Bone Marrow Transplant
. 2023 Apr;
58(7):742-748.
PMID: 37024570
Autologous chimeric antigen receptor-modified T-cells (CAR-T) provide meaningful benefit for otherwise refractory malignancies. As clinical indications for CAR-T cells are expanding, hospitals hitherto not active in the field of immune...
8.
9.
10.
Vrielink H, Le Poole K
Transfus Apher Sci
. 2023 Mar;
62(2):103673.
PMID: 36872123
In patients with an end-stage renal disease, dialysis a or kidney transplant are required to prolong live. For survival of the transplanted kidney, besides the HLA-system, the ABO blood type...